Congressional committees with jurisdiction over health care legislation continue to focus on the opioid crisis:

In other policy areas:

  • The House Oversight Committee held a hearing on federal and state efforts to identify, prevent, and recover improper payments made through state Medicaid programs (a related OIG report is available here).
  • On April 24, the Senate HELP Committee will consider three pending Senate bills (in addition to the opioid legislation noted above): S.2315, to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application; S.2597, to amend the Public Health Service Act to reauthorize the program of payments to children’s hospitals that operate graduate medical education programs; and S.382, to require the Secretary of Health and Human Services to develop a voluntary registry to collect data on cancer incidence among firefighters.
  • The House Ways and Means Health Subcommittee is holding an April 26 hearing on innovative practices and technology that physicians, other providers, and various organizations are implementing.